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Abstract
Background. Malignant brain tumors are unpredictable and incurable, with 5-year survival rates less than 30%. The poor
prognosis combined with intensive treatment necessitates the inclusion of complementary and supportive therapies that
optimize quality of life and reduce treatment-related declines in health. Exercise therapy has been shown to be beneficial
in other cancer populations, but no evidence is available for brain cancer survivors. Therefore, we report results from 2
preliminary cases. Methods. Two female patients diagnosed with glioblastoma multiforme and oligodendroglioma participated
in a structured and supervised 12-week exercise program. The program consisted of two 1-hour resistance and aerobic
exercise sessions per week and additional self-managed aerobic sessions. Outcome measures of strength, cardiovascular
fitness, and several psychological indicators (depression, anxiety, and quality of life) were recorded at baseline, after 6 weeks
and at the conclusion of the intervention. Results. Exercise was well tolerated; both participants completed all 24 sessions
and the home-based component with no adverse effects. Objective outcome measures displayed positive responses relating
to reduced morbidity. Similar positive responses were found for psychological outcomes. Scores on the Hospital Anxiety
and Depression Scale showed clinically meaningful improvements in depression and total distress. Conclusion. These findings
provide initial evidence that, despite the difficulties associated with brain cancer treatment and survivorship, exercise may
be safe and beneficial and should be considered in the overall management of patients with brain cancer.
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Introduction
Brain cancer is a devastating and highly debilitating form of
cancer. In 2014, there were an estimated 23 000 new cases
of brain and nervous system cancers in the United States
alone.1 This number is fairly low compared to the incidence
of breast or prostate cancer but is particularly challenging
because of the poor prognosis for brain tumors; approximate 5-year survival rates are less than 30%,2 and there is
a mean survival time of approximately 15 months for
glioblastoma, the most common malignant brain tumor.3
Moreover, brain cancer is one of very few tumor sites that
have not seen a decline in mortality over the past 20 years.4
The impact of brain cancer and its associated treatments
often results in impaired physical capabilities, mild or major
cognitive dysfunction, and compromised psychological
well-being.5,6 Therefore, adjuvant and supportive care that
facilitates an improved quality of life and reduces these
adverse effects should be considered for brain cancer survivors (we use the term survivor in accordance with the

definition by National Coalition for Cancer Survivorship as
someone who has been diagnosed with cancer and is still
alive, regardless of the stage of their disease or the treatment that they are receiving).7 A large body of evidence has
emerged to support the prescription of exercise as a therapeutic and supportive form of care for cancer survivors.
Indeed, the American College of Sports Medicine (ACSM)
and the American Cancer Society (ACS) are among the
many international organizations that have specific exercise
guidelines for cancer survivors.8,9 These guidelines were,
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however, compiled from research outcomes comprising
breast, prostate, colon, hematological, and gynecological
cancers. Therefore, the potential beneficial impact of
exercise for brain cancer survivors remains unknown.
Nonetheless, previous research has pointed toward a relationship between exercise engagement and survival time
in recurrent glioma patients.10 Additionally, Cormie et al11
recently presented a theoretical perspective of the potential
impacts of including exercise as a form of supportive care
for neuro-oncology survivors.
Therefore, this report aims to contribute to empirical
evidence by describing the outcomes of 2 distinct case
studies of brain cancer survivors who undertook a 12-week
structured and supervised exercise program by highlighting clinically important outcomes, including the ability to
tolerate and adhere to the exercise program.

Methods
Participants
Two case studies have been drawn from a larger feasibility
trial that aimed to examine exercise for the management of
depression in depressed cancer survivors.12 These were the
only 2 brain cancer survivors within the trial who met
inclusion criteria for participation: (1) able to understand
written English; (2) able to walk 400 m unassisted; (3) family
physician consent confirming no musculoskeletal, cardiovascular, or neurological limitations; and (4) elevated
depressive symptoms at baseline. This case study examination is unique because the 2 participants were diagnosed
with different brain tumors and were at various stages
within their cancer care continuum. Participant A (58 years
old, 163 cm, 66.4 kg, 62 months postdiagnosis) was first
diagnosed with low-grade glioma in the right frontal lobe in
2007, which was treated with surgical resection. She underwent repeat resection in 2012 for recurrent disease followed
by radiotherapy. Her disease at this time transformed to
grade III anaplastic oligodendroglioma. On commencement of the exercise program, her medications included
thyroxine, lamotrigine, sertraline, calcium, and latanoprost.
Participant A was 288 months postdiagnosis for clinical
depression and had a history of pharmacotherapy and psychotherapy, including current antidepressant medication.
Participant B (61 years old, 164 cm, 59.4 kg, 5 months
postdiagnosis) was diagnosed with right frontal lobe
glioblastoma multiforme in December 2012. She received
standard treatment consisting of surgical excision followed
by concurrent radiotherapy with temozolomide chemotherapy. She developed progressive disease despite these
treatments. She was receiving intravenous bevacizumab
fortnightly when she entered the exercise trial. Her other
medications included levetiracetam, dexamethasone,
omeprazole, vitamin D, and temazepam. Participant B had

not been clinically diagnosed with depression but presented
with severe symptomatology according to the Hospital
Anxiety and Depression Scale (HADS; see Table 1). Neither
participant had any other diagnosed illness or chronic
disease. Both were female, married, and educated to a
bachelor’s degree level. Both participants were supportive
of the research and provided written informed consent.

Exercise Intervention
A 12-week exercise intervention, performed twice weekly,
was supervised by an accredited exercise physiologist. Each
supervised exercise session consisted of 20 minutes of
moderate to vigorous aerobic exercise (eg, treadmill,
cycling ergometer, rowing ergometer) and 40 minutes of
resistance training. The resistance training targeted all the
major upper- and lower-body muscle groups, using the
following 9 exercises: chest press, leg press, lateral pulldown, knee extension, knee flexion, seated row, lateral
shoulder raises, step up, and bicep curls. The load of external
resistance was established in the first 2 weeks and subsequently increased to ensure that the participants always
performed at a specified intensity. In the first 2 weeks,
participants performed 2 sets of 12 repetitions (2 × 12),
followed by 3 × 10 for 4 weeks, 3 × 8 for 3 weeks, and
4 × 6 for the final 3 weeks. The 2 supervised exercise sessions
were supplemented with additional home-based aerobic
exercise. Participants were encouraged to accumulate a
total of 150 minutes of aerobic exercise, not including their
2 resistance training sessions, to meet recommended physical
activity guidelines of 150 min/wk.8 A home-based activity
log was provided at baseline and monitored regularly.

Outcome Measures
Objective physical and physiological measures, along
with subjective patient-reported outcomes (PROs), were
recorded at baseline, after 6 weeks, and again after completion of the 12-week program. All measures were collected
in a single 90-minute session at the university health and
wellness institute. All measures were taken in the same
order at each testing session.
Physical and Physiological Measures
Aerobic adaptations. To examine cardiovascular adaptations to exercise, oxygen consumption (VO2) and heart rate
(HR) responses were measured during the first 2 stages of
a modified Bruce Treadmill protocol.13 These stages correspond to velocities of 2.7 and 4.0 km/h at gradients of
10% and 12%, respectively. Oxygen uptake was measured
through indirect calorimetry (Parvo Metabolic Measuring
System, Sandy, UT). Additionally, the participants performed a 400-m long corridor walk test, which can be used
as a measure of physical function and act as a surrogate
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Table 1. Outcome Measures Reported for Each Assessment Point for Both Participants.
Participant A
Baseline
VO2 (ml/kg/min)
Rest
Stage 1
Stage 2
Heart rate (bpm)
Rest
Stage 1
Stage 2
Functional fitness
400 m walk (s)
Strength (kg)
Chest press 1-RM
Leg press 1-RM
Body composition
Lean mass (kg)
Fat mass (kg)
Percentage body fat (%)
MHC: SF-36
PHC: SF-36
HADS
HADS-D
HADS-A
SWLS
CASES
PSQI
Exercise engagement
Total (min/wk)
Exercise intensity (min/wk)
Mild
Moderate
Strenuous

Participant B

6 Weeks

12 Weeks

Baseline

6 Weeks

12 Weeks

3.45
14.51
22.32

5.36
15.56
21.35

4.99
13.75
19.27

5.47
15.13
20.79

4.78
15.34
18.91

5.45
15.65
20.32

79
101
119

74
97
115

72
93
111

93
103
110

81
96
109

74
86
103

258.6

251.8

248.7

250.5

241.6

231.3

17.5
76.5

20.0
76.5

20.0
90.0

12.5
49.5

17.5
58.5

20.0
72.0

39.1
25.3
38.0
34.70
47.52
23
10
13
11
115
16

38.1
25.7
39.0
28.91
46.86
18
8
10
19
119
17

36.9
26.1
40.1
33.68
50.65
14
6
8
29
149
12

36.5
21.4
35.9
27.39
46.24
24
12
12
7
110
12

36.5
19.8
34.1
28.64
41.51
27
15
12
5
111
14

37.9
18.7
32.0
54.77
38.36
13
6
7
17
156
15

240

405

220

180

250

450

0
60
180

105
60
240

100
0
120

60
120
0

90
160
0

315
135
0

Abbreviations: VO2, oxygen consumption; bpm, beats per minute; 1-RM, 1 repetition maximum; MHC, mental health composite; PHC, physical health
composite; SF-36, Short Form 36; HADS, Hospital Anxiety and Depression Scale; HADS-D, HADS depression subscale; HADS-A, HADS anxiety
subscale; SWLS, Satisfaction with Life Scale; CASES, Cancer Self-Efficacy Scale; PSQI, Pittsburgh Sleep Quality Index.

measure of aerobic capacity.14,15 Performance was assessed
by measuring the time taken to complete this task.
Muscle strength and body composition. Maximal concentric muscle strength was assessed for the upper (chest press)
and lower (leg press) body using the 1 repetition maximum
(1-RM) method.16 Participants performed a graded warm-up
consisting of one set of 6 repetitions at a light weight, followed by a second set of 3 lifts at a heavier weight. Thereafter,
single lift sets were performed until reaching the 1-RM; the
weight that could be lifted only once with correct form and
technique.14 All 1-RMs were determined within 5 attempts.
Changes in total body lean muscle and fat mass composition
and percentage body fat were assessed using dual energy X-ray
absorptiometry (DXA, Hologic Discovery A, Waltham, MA).

Patient-Reported Outcomes. Several well-validated questionnaires examined psychosocial outcomes. Measures included
quality of life, depression, anxiety, total distress, satisfaction
with life, cancer-specific self-efficacy, and sleep quality.
Quality of life was recorded using the Short Form-36 v2
(SF-36),17 which comprises 8 subscales of the SF-36, and
the 2 composite scores of physical (PHC) and mental
(MHC) health are reported. These composite scores are presented for comparison to the normalized mean T score of 50
and a standard deviation of 10.18 Depression (HADS-D),
anxiety (HADS-A), and total distress were all recorded using
the HADS.19 Although the HADS is a single 14-question
scale, the use of the individual subscales to assess anxiety and
depression independently is well supported.20 Satisfaction
with life was measured using the brief 5 questions of the
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Satisfaction With Life Scale (SWLS).21 The ability to
manage living with cancer was measured using the Lewis
Cancer Self-Efficacy Scale (CASES).22,23 This questionnaire comprises 17 items (eg, “I am able to manage what is
being asked of me despite the cancer”) that are scored on an
11-point Likert scale ranging from 0 (not at all confident) to
10 (very confident). In accordance with the authors’ instructions, participants were asked to rate their level of confidence to manage or cope with cancer-related problems for
that particular day. Higher scores represent increased selfefficacy. Finally, the Pittsburgh Sleep Quality Index (PSQI),
which measures sleep outcomes over the previous 1-month
period was used to assess changes in sleep quality.24

It is important to note that no adverse events occurred
throughout the intervention. Both participants demonstrated
100% adherence, attending all 24 scheduled sessions.
Furthermore, participant A completed an additional 35
home-based aerobic sessions, 16 in the first 6 weeks and 19
in the following 6 weeks. Participant B completed an additional 44 sessions over the 12 weeks, 22 in each 6-week
period. Both participants were highly active at baseline, but
still managed to increase their exercise engagement for the
first 6 weeks; thereafter, participant A declined below baseline levels, whereas participant B continued to increase,
more than doubling her total physical activity minutes
compared with baseline levels.

Physical Activity and Exercise Adherence. A modified version of
the Godin Leisure Time Exercise Questionnaire was used to
determine physical activity levels.25 This questionnaire asks
participants to record how often they performed exercise in
the previous week and to categorize the intensity of each
session as mild, moderate, or strenuous. Two modifications
were made to the original questionnaire to accurately quantify exercise activity. First, the minimum time requirement
was lowered from 15 to 10 minutes, which is more in line
with current exercise guidelines suggested by the ACSM.26
Second, the average duration of each session was reported.
These changes allowed for the determination of whether
an individual was meeting international physical activity
guidelines for cancer survivors.8 Exercise adherence was
measured by comparing the total number of sessions
attended with the number scheduled over the 12 weeks.

Discussion

Results
Objective assessments showed improvements in physical
health indicators in both participants; however, the patterns
of improvement were not always similar (Table 1). Both
participants showed an improvement in cardiovascular efficiency demonstrated by the comparatively lower HR at each
stage across time and a reduction in time to complete the
400-m walk test. However, they displayed variable oxygen
consumption responses. Maximal strength, summed as the
total of the upper- and lower-body exercise tests, increased
by 17% and 48%, regardless of the variable body composition responses. Subjective PROs also varied between the 2
participants. However, over the entire 12-week program,
there was a consistent improvement for all mental health
outcomes. Both participants showed clinically meaningful
reductions in depression, anxiety, and total distress, reducing
symptomatology below cutoff scores used to represent
clinical caseness.27 This change occurred with concomitant
increases in satisfaction with life (SWLS) and cancer coping
self-efficacy (CASES). Little change was noted for sleep
quality, and both participants consistently reported scores
above 5, which is used to indicate sleep disturbance.24

The aim of this report was to examine whether a 12-week
structured and supervised exercise program was beneficial
and of clinical benefit within a supportive care framework
for cancer survivors with brain tumors. Two unique participants, who presented with common tumors and at vastly
different stages of prognoses, participated in a similar exercise program, individualized only by intensity but not by
exercise selection. The results achieved by both participants
present initial evidence indicating that physical and mental
health is enhanced after commencing a supervised, structured, and professionally led exercise program.
In line with expectations from a structured and supervised exercise program, both participants increased muscle
strength and cardiovascular fitness. These findings are clinically important for several reasons. First, both participants
were already active and meeting physical activity recommendations set by the ASCM for cancer survivors.8 Therefore,
based on the dose-response theory, the 2 participants had a
reduced capacity for physical improvement compared with
inactive survivors,26,28 which may account for the relatively
low percentage increase in maximal strength shown by
participant A. Second, the medications prescribed for the 2
participants as well as the ongoing chemotherapy (bevacizumab) for participant B are known to have deleterious
effects on physical function and fitness. It is well documented that patients undergoing chemotherapy and radiation therapy experience treatment-related symptoms (eg,
fatigue, reduced strength, and reduced fitness),29-31 and
when used in combination, these effects are magnified and
can be long lasting.32 Both these participants had previous
exposure to cranial radiotherapy and participant B also had
multiple sessions of chemotherapy. Additionally, both participants were taking prescribed antiepileptic medications
(lamotrigine and levetiracetam), which also commonly present lead to symptoms of headaches, nausea, and fatigue.33
These medications and adverse effects have a multiplicative
effect in reducing the capacity for physical activity.
Therefore, the improvements for these 2 participants likely
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occurred when decrements in cardiorespiratory fitness
and muscle strength may otherwise have been expected.
Notably, the continued engagement in moderate to vigorous
exercise may have the potential not only to decrease
morbidity, but also decrease mortality. Previous research by
Ruden et al10 illustrated that engaging in regular higherintensity exercise was associated with increased survival
for survivors of recurrent brain cancer. However, the current trial was not designed with survival as an end point.
Current evidence suggests that screening and treating
depression in patients with brain cancer should be a primary
concern for comprehensive care.34 Distress has been classified as the sixth vital sign, and best-practice cancer care
should attend to the emotional and psychosocial needs of
each patient.35 Previous reports indicate that approximately
50% of neurological cancer survivors suffer with elevated
distress.36 The 2 participants were included within the larger
trial particularly because they were distressed; nonetheless,
in this regard, they are likely very representative of the
clinical population. The 2 participants both had clinically
meaningful reductions in depression and total distress,
measured using the HADS,27,34 after the 12-week exercise
intervention. These outcomes are in line with evidence that
exercise reduces depression in depressed individuals37 as
well as comorbid depression in people with cardiovascular
disease38 and are unlikely to be attributed to any response
from medications because these were consistent before and
during the intervention period.
There was also a large and clinically meaningful categorical shift in satisfaction with life. The scale allows a range of
5 to 35. Categorical scoring zones have been provided by the
authors, with each 5-point block (eg, 5-9, 21-25) representing an increased level of satisfaction with life21; a score of 20
is classified as the neutral threshold value for this scale.39 At
baseline, both participants scored on the lower end of the
scale (11 and 7), but by the conclusion of the exercise
intervention, participant A increased 3 categorical levels,
exceeded the neutral threshold, and fell within the “high”
category. Participant B increased 2 categorical levels from
“extremely dissatisfied” to “slightly below average” and
was just 1 point short of reaching the neutral threshold.
Interestingly, the improvements in objective physical
assessments as well as the improved mental health measures occurred independently of self-rated physical health
(PHC from the SF-36), which remained relatively stable for
participant A and declined considerably for participant B.
Specifically, for participant A, this may have been partly a
result of overtraining because she reported increased
fatigue. Therefore, after 6 weeks participant A was advised
by the exercise physiologist to reduce her total exercise
load. The decline in PHC SF-36 score for participant B may
be explained by the ongoing pharmacotherapy, which
caused unexpected adverse events such as nosebleeds
because of blood thinning. This suggests that a general
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measure of health-related quality of life may not be an
appropriate or clinically meaningful PRO to assess the
effectiveness of an exercise program in neuro-oncology
patients, who can have rapidly changing subjective opinions of their health status based on compromised immune
systems and increased risk of illness or negative prognostic
feedback from treating clinicians.
This exercise program was supported by the treating
oncologist of both participants as well as their respective
family physicians. This process of approval by clinicians
should be considered as best practice to ensure that there are
no contraindications to exercise. While recuperating from
cancer treatment, the introduction or continuation of physical activity to enhance recovery, reduce toxicity, increase
physical function, and improve health-related quality of life
has been recommended by the ACSM8 and further endorsed
by the ACS.9 The findings reported above, along with new
and emerging evidence, suggests that exercise is safe and
beneficial for even the most complex cancer cases, including patients with bone metastases40 and those with poor
prognoses, including pancreatic cancer patients.41
In summary, the outcomes from this report are intended
to build a level of evidence regarding the benefits of exercise for cancer survivors with brain tumors. However, both
participants were active at baseline, which may limit the
generalizability of these findings. Moreover, the duration of
the intervention was relatively short. Nonetheless, for these
particular survivors, there were some important and clinically relevant outcomes. If exercise is to be included as
standard care, it is essential to build on these results and
determine whether patients with brain cancer continue to
improve over longer periods of time and whether they are
able to maintain the adherence levels seen in this study.
These 2 cases illustrate that, in some cases, exercise is a
beneficial form of supportive care, improving compromised mental health and enhancing physical capacity for
brain cancer survivors, regardless of whether they are in
palliative care or have exceeded the median expectations
for survival. However, more evidence, including larger
clinical and controlled trials, is required before these results
can be broadly translated into clinical practice for all brain
cancer survivors.
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